Zobrazeno 1 - 10 of 13 pro vyhledávání: '"Anita Compan"'
1
Akademický článek
Soluble Markers of Immune Activation Differentially Normalize and Selectively Associate with Improvement in AST, ALT, Albumin, and Transient Elastography During IFN-Free HCV Therapy
Autor: Lenche Kostadinova, Carey L. Shive, Elizabeth Zebrowski, Brianna Fuller, Kelsey Rife, Amy Hirsch, Anita Compan, Anita Moreland, Yngve Falck-Ytter, Daniel L. Popkin, Donald D. Anthony
Publikováno v: Pathogens and Immunity, Vol 3, Iss 1, Pp 149-163 (2018)
Background: During chronic hepatitis C virus (HCV) infection, Aspartate Aminotransferase (AST) and Alanine Aminotransferase (ALT) levels mark active liver inflammation and tissue damage, while albumin reflects synthetic liver function and nutritional
Externí odkaz: https://doaj.org/article/a651cb373a704c528bb45bc7a62bed87
Zobrazit plný text záznamu
2
Akademický článek
Treatment Selection Choices Should Not Be Based on Benefits or Costs Alone: A Head-to-Head Randomized Controlled Trial of Antiviral Drugs for Hepatitis C.
Autor: Perica Davitkov, Apoorva Krishna Chandar, Amy Hirsch, Anita Compan, Marina G Silveira, Donald D Anthony, Suzanne Smith, Clare Gideon, Robert A Bonomo, Yngve Falck-Ytter
Publikováno v: PLoS ONE, Vol 11, Iss 10, p e0163945 (2016)
Clinicians often face dilemmas with decisions related to formulary choices when two similar drugs are simultaneously available in the market. We studied the comparative safety, effectiveness, and treatment costs of the two first generation direct-act
Externí odkaz: https://doaj.org/article/e0b28ffe2d2742a7978d941a3ceda23c
Zobrazit plný text záznamu
4
Genetically Associated CD16+56− Natural Killer Cell Interferon (IFN)–αR Expression Regulates Signaling and Is Implicated in IFN-α–Induced Hepatitis C Virus Decline
Autor: Nicole L. Yonkers, Gareth Hardy, Sara J. Conry, Donald D. Anthony, Perica Davitkov, Clifford V. Harding, Anita Compan, Qinglai Meng, Amy Hirsch, Benigno Rodriguez, Ronald E. Blanton, Julia M. Sugalski, Yngve Falck-Ytter
Publikováno v: The Journal of Infectious Diseases. 205:1131-1141
Acute hepatitis C virus (HCV) infection becomes persistent in a majority of cases [1], and the long-term risk of cirrhosis, liver failure, cancer, and mortality among those with chronic infection highlight the importance of effective therapy [1, 2].
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05513f30ef980d0d68161c10f7444e01
https://doi.org/10.1093/infdis/jis027
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje